Bixiye
QP37-16 Difference in Operating Systems Identified - GY Modifier
Taariikhda uu dhaqangalayo Barnaamijka: Des 09, 2016
Natiijooyinka Raadinta
Soo bandhiga 2461 - 2470 ee natiijooyinka 4296
Bixiye
QP17-16 Claims with Attachments
Taariikhda dhaqangalka Barnaamijka: Jul 26, 2016
Bixiye
QP100-18 Pharmacy Benefit Exclusion for Crinone (progesterone) Gel, Finacea (alzelaic acid) Foam, Glatopa (glatiramer acetate) Injection
Taariikhda uu dhaqangalayo Barnaamijka: Nov 28, 2018
Bixiye
QP1-18 Transition of Care Management Features for New Medicare Advantage Prescription Drug Plans
Taariikhda uu dhaqangalayo Barnaamijka: Jan 08, 2018
Bixiye
QP11-16 New BlueRide Email Notification Option for SNF
Taariikhda uu dhaqangalayo Barnaamijka: May 04, 2016
Bixiye
QP44-17 New Pre-Authorization Form for Botulinum Toxin for Commercial Products
Taariikhda uu dhaqangalayo Barnaamijka: Des 05, 2017
Bixiye
QP12-17 Prior Authorization/Pre-Approval Forms Specific to Select Medical Policies
Taariikhda uu dhaqangalayo Barnaamijka: May 31, 2017
Bixiye
QP32-16 Centurion Contracts with BlueLink TPA for Claims Administration Servicesa
Taariikhda uu dhaqangalayo Barnaamijka: Nov 18, 2016
Bixiye
QP34-18 Pharmacy Benefit Update - New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Uric Acid Transport 1 (URAT1) Inhibitor
Taariikhda uu dhaqangalayo Barnaamijka: May 15, 2018